The project has reduced the level of HIV contagion from mother to newborn, through a series of preventive measures, among them a consultation service for pregnant women. The initiative concerns people living in the three regions of Angola also involved in the Salissa Mwana project. The medical facilities and laboratory at the city of Pointe-Noire have equipment for free HIV screening and radiological and general tests. The heart of the initiative was the University of Genoa's on-site launch of an advanced diagnostics laboratory for studying HIV infection, with our support. We extended the prevention programme to other diseases (in particular the hepatitis B virus) and provided a pre-emptive vaccination for the babies of infected women. Women with HIV were also given antiretroviral drugs and benefited from getting more iron and vitamins. In all cases we provided blood chemistry, radiological and general tests, and where necessary, admitted people to hospital.
We also focused on medical staff training, for 781 doctors, centre managers, counsellors, obstetricians, nurses, midwives and laboratory technicians. The medical team took part in various training sessions, on counselling before and after HIV tests, taking care of infected women during pregnancy and labour, and looking after newborns. Finally, staff were trained on safety when taking blood samples, HIV tests and potentially toxic antiretroviral drugs. At the same time, two Congolese doctors did a specialist internship on managing HIV infection at the University of Genoa.
1/1
Important data at the project's end
Three Angolan regions involved
30,487Women
given consultation
To reduce the level of HIV contagion from mother to newborn
The 2030 Agenda for Sustainable Development is an action programme signed in September 2015 by 193 UN member states. It includes 17 goals for socio-economic development of communities and local areas. In line with goal 3, in the Kento Mwana project we wanted to ensure health and well-being for people (Goal 3).
In four years, we have helped improve the performance of the area’s healthcare facilities, trained staff and strengthened preventive measures to protect women from diseases contracted during pregnancy.
For us, workplace safety is a fundamental principle that we share with employees, contract workers and local communities. That is why we implement all the necessary measures to avoid accidents, including organisational models to assess and manage risks, training programmes, skills development and the promotion of a culture of safety.
The Eni Foundation funded and ran the project in collaboration with the Congolese Ministry of Health, Conseil National de Lutte contre le SIDA (CNLS) and the infectious disease clinic at the University of Genoa, whose specialist staff organised operations.
This website uses cookies to show you adverts and offer you services customised according to the preferences you have shown while browsing online. For further information please refer to our cookie policy.
THIS WEBSITE (AND THE INFORMATION CONTAINED HEREIN) DOES NOT CONTAIN OR CONSTITUTE AN OFFER OF SECURITIES FOR SALE, OR SOLICITATION OF AN OFFER TO PURCHASE SECURITIES OR IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR FOR THE ACCOUNT OR BENEFIT OF ANY U.S. PERSON AS THAT TERM IS DEFINED IN THE SECURITIES ACT (A "U.S. PERSON"), AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH AN OFFER OR SOLICITATION WOULD REQUIRE THE APPROVAL OF LOCAL AUTHORITIES OR OTHERWISE BE UNLAWFUL (THE "OTHER COUNTRIES"). THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR PURSUANT TO THE CORRESPONDING REGULATIONS IN FORCE IN AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR THE “OTHER COUNTRIES” AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO A U.S. PERSON UNLESS THE SECURITIES ARE REGISTERED UNDER THE SECURITIES ACT, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT IS AVAILABLE. NO PUBLIC OFFERING OF SUCH SECURITIES IS INTENDED TO BE MADE IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR IN THE “OTHER COUNTRIES.”
In any Member State of the European Economic Area ("EEA"), the information contained in this website is only directed at and may only be communicated to persons who are "qualified investors" ("Qualified Investors") within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (the "Prospectus Regulation").
The information to which this website gives access is directed only at persons (i) who are persons falling within Article 49(2)(a) to (d) ("high net worth companies, unincorporated associations etc.") of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (ii) who have professional experience in matters relating to investments falling within Article 19(5) of the Order or (iii) to whom it may otherwise lawfully be communicated (all such persons together being referred to as "relevant persons"). Any investment or investment activity to which this communication relates is only available to relevant persons and will be engaged in only with relevant persons, or in the EEA, with Qualified Investors. Any person who is not a relevant person, a Qualified Investor or otherwise permitted under applicable law or regulation to access the information, should not act or rely on the information contained herein.
Confirmation of Understanding and Acceptance of Disclaimer
These materials are for informational purposes only and are not directed to, nor are they intended for, access by persons located or resident in the United States, Australia, Canada, Japan or South Africa or any of the Other Countries. I certify that:
I am not resident of, or located in, the United States, Australia, Canada, Japan or South Africa or any of the Other Countries or I am not a U.S. Person; or
If I am a resident of, or located in, the EEA, I am a Qualified Investor within the meaning of Article 2(e) of the Prospectus Regulation; or
If I am a resident of, or located in, the United Kingdom, I am a Qualified Investor and a relevant person.
I have read and understood the disclaimer set out above. I understand that it may affect my rights. I agree to be bound by its terms and I am permitted under applicable law and regulations to proceed to the following parts of this website.
WARNING: the above certification constitutes a "self-certification" pursuant to Decree of the President of the Italian Republic No. 445 of 28 December 2000. False certifications are punishable by law.
